Descripción del proyecto
Ética y progreso tecnológico en la medicina de la reproducción femenina
La medicina de la reproducción abarca todos los aspectos de la vida humana, desde la fertilización hasta el nacimiento, y emplea tratamientos con asistencia médica para solucionar problemas que puedan surgir con la concepción natural. En un mundo en el que la tecnología progresa a un ritmo muy rápido, el objetivo del proyecto ERIN, financiado con fondos europeos, es aportar a la medicina innovaciones con un talante más ético, como la conservación de la fertilidad en mujeres en riesgo de perderla y el análisis genético del embrión. Los socios del proyecto analizarán todos los problemas, los riesgos y las vulnerabilidades de carácter ético que pudieran plantearse en relación con las nuevas tecnologías para la reproducción, y sentará las bases para generar métodos con una mayor conciencia. Estas medidas garantizarán la igualdad de oportunidades en el acceso a la medicina reproductiva, lo que asistirá a pacientes vulnerables a la espera de dar a luz .
Objetivo
ERIN project was initiated to spread the academic excellence to University of Tartu (UT) in Estonia as representative of the Widening country, by enhancing networking activities with internationally-leading counterparts, Karolinska Institute (Sweden) and Maastricht University Medical Centre (The Netherlands).
The consortium increases the scientific, innovation and clinical superbness of UT and its partners, by raising the R&I profiles, and the proficiency to identify, explore and resolve the ethical challenges in female reproductive medicine. We deal with the most intimate aspects of human life, by medically assisting conception, by carrying out a genetic analysis of an embryo or fetus to have a healthy baby, and by preserving fertility in women whose fertility is at risk. In the era of rapidly progressing technologies, novel solutions emerge fasten than the conclusive clinical evidence is collected and ethical challenges are addressed. Reproductive medicine is also often unsatisfactorily publicly supported, creating an inequality in access for the most vulnerable category of the patients, women waiting for childbirth.
This is why reproductive medicine, covering human life from fertilization till birth, requires special attention to tackle all possible ethical concerns, risks and vulnerabilities, and involving all stakeholders, from individual patients to broad community. By addressing these challenges, we aim to bring more ethically responsible innovations into clinic that do not harm the interests of the various stakeholders, are evidence-based, cost-effective and therefore could be implemented in a sustainable way to ensure that these novel solutions become widely accessible.
As an outcome, ERIN improves the responsible innovation practices, establish ethical system in R&I, expands knowledge and innovation capacity of the UT, and improves proficiency of all partners to facilitate the equity of access to research advances in reproductive medicine.
Ámbito científico
Palabras clave
Programa(s)
- H2020-EU.4.b. - Twinning of research institutions Main Programme
Tema(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-WIDESPREAD-2020-5
Régimen de financiación
CSA - Coordination and support actionCoordinador
51005 Tartu
Estonia